Glizid 40 mg (Gliclazide)

Product Overview

Glizid 40 mg is a prescription oral antidiabetic manufactured by Panacea Biotech Ltd. It is indicated for the management of type 2 diabetes mellitus when diet and exercise alone are insufficient. The medication is supplied in strips containing ten tablets each, with pack sizes of 60, 90 or 120 tablets available to suit patient needs. This product combines proven efficacy with a well‑established safety profile, making it a reliable option for clinicians seeking consistent glycemic control.

What is Glizid 40 mg?

Glizid contains gliclazide, a sulfonylurea class agent that lowers blood glucose by stimulating pancreatic beta cells to release insulin. The 40 mg strength provides a mid‑range dose that can be titrated based on patient response. Although the active ingredient is listed as nan in the source data, the pharmaceutical formulation delivers 40 mg of gliclazide per tablet, ensuring consistent bioavailability and therapeutic effect.

Uses and Benefits

The primary use of Glizid 40 mg is to improve glycemic control in adults with type 2 diabetes. Regular use, together with a balanced diet and physical activity, helps reduce HbA1c levels and diminishes the risk of diabetes‑related complications such as neuropathy, retinopathy and cardiovascular disease. Patients often experience sustained glucose lowering without the need for multiple daily injections, which can improve adherence and quality of life.

How It Works

Gliclazide binds to the sulfonylurea receptor (SUR1) on the surface of pancreatic beta cells, leading to closure of potassium channels and subsequent calcium influx. This sequence triggers insulin secretion in a glucose‑dependent manner, meaning that insulin release occurs only when blood glucose is elevated, thereby minimizing the chance of excessive hypoglycemia. In addition, gliclazide may modestly improve insulin sensitivity, contributing to better overall glucose metabolism.

Dosage Guidelines

The recommended initial dose of Glizid 40 mg is one tablet taken orally once daily with the first main meal of the day. Dosage may be increased in increments of 40 mg at intervals of 1–2 weeks, up to a maximum of 120 mg per day, depending on the patient’s glycemic response and tolerability. It is essential to monitor blood glucose regularly and adjust the dose only under medical supervision. Patients with renal impairment may require dose reduction, and the drug should be used with caution in elderly populations.

Side Effects

Like all medications, Glizid can cause adverse effects. The most commonly reported side effects include hypoglycemia, weight gain, nausea, and mild gastrointestinal discomfort. Less frequent but serious adverse reactions may involve hepatic enzyme elevations, severe hypoglycemia requiring emergency care, and hypersensitivity reactions such as rash or angioedema. Patients should be instructed to recognize the signs of low blood sugar, such as sweating, trembling, confusion, or dizziness, and to treat episodes promptly with glucose‑containing foods or medical assistance if needed.

Warnings and Precautions

Glizid 40 mg is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or a history of hypersensitivity to gliclazide or any component of the formulation. Caution is advised in individuals with severe renal or hepatic disease, as well as those with adrenal or pituitary insufficiency. Concomitant use of other antidiabetic agents, certain antibiotics, or alcohol can increase the risk of hypoglycemia. Pregnant and breastfeeding women should avoid this medication unless a physician determines that the benefits outweigh the risks. Always store the medication in a dry place, away from direct heat and out of reach of children.

Frequently Asked Questions

What is the strength of Glizid tablets? Each tablet delivers 40 mg of gliclazide, the active ingredient that helps lower blood glucose in adults with type 2 diabetes.

How should I store Glizid? Keep the strips in a cool, dry place, away from moisture and direct sunlight. Do not use the medication after the expiration date printed on the packaging.

Can Glizid be taken with other diabetes medicines? It may be used in combination therapy, but the dose of the accompanying agent should be adjusted to avoid excessive glucose lowering. Always consult a healthcare professional before combining treatments.

Is Glizid safe for patients with kidney disease? Patients with impaired renal function may need a reduced dose, as the drug is primarily eliminated through the kidneys. A physician will determine the appropriate adjustment based on measured creatinine clearance.

Where can I find more detailed prescribing information? Detailed drug information, including the FDA‑approved label, is available at reputable sites such as the U.S. Food and Drug Administration FDA Drugs Portal, the National Institutes of Health NIH Diabetes Resources, and MedlinePlus MedlinePlus Gliclazide Page.